An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation

BACKGROUND: For more than 240 million chronic HBV carriers worldwide, effective therapeutic HBV vaccines are urgently needed. Recently, we demonstrated that autophagosomes were efficient antigens carriers and capable to cross-prime robust T-cell responses and mediate regression of multiple establish...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Meng, Fan, Fei, Ding, Lei, Liu, Jingyu, Su, Shu, Yin, Pengfei, Cao, Meng, Zhao, Wei, Hu, Hong-ming, Wang, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301925/
https://www.ncbi.nlm.nih.gov/pubmed/25526800
http://dx.doi.org/10.1186/s12967-014-0361-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301925/
https://www.ncbi.nlm.nih.gov/pubmed/25526800
http://dx.doi.org/10.1186/s12967-014-0361-4

Ejemplares similares